ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Stem Cell Drugs Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-8G8235
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global and Japan Stem Cell Drugs Market Insights Forecast to 2027
BUY CHAPTERS

Global Stem Cell Drugs Market Research Report 2025

Code: QYRE-Auto-8G8235
Report
July 2025
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
JCR Pharmaceuticals Co Ltd
Corestem Inc
PHARMICELL
ANTEROGEN CO LTD
Chiesi Pharmaceuticals
Takeda
New York Blood Center
MediPost Co Ltd

Stem Cell Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Stem Cell Drugs Market

Stem Cell Drugs Market

The global market for Stem Cell Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Stem cell drugs is the use of in vitro isolation, culture, and targeted differentiation of stem cells to cultivate a new, normal, and younger type of cells, tissues, and organs. It is transplanted into the body through special transplantation technology to replace normal or abnormally dead cells, thereby restoring body function
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Stem Cell Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stem Cell Drugs.
The Stem Cell Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Stem Cell Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Stem Cell Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Stem Cell Drugs Market Report

Report Metric Details
Report Name Stem Cell Drugs Market
CAGR 5%
Segment by Type
  • Cord Blood-Derived
  • Adipose-Derived
  • Bone Marrow-Derived
  • Others
Segment by Application
  • Acute Graft-versus-Host Disease
  • Crohn’s Disease
  • Amyotrophic Lateral Sclerosis
  • Osteoarthritis
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company JCR Pharmaceuticals Co., Ltd, CORESTEM, Inc, Pharmicell Co., Ltd, Anterogen, Chiesi Pharmaceuticals, Takeda, New York Blood Center, MEDIPOST
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Stem Cell Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Stem Cell Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Stem Cell Drugs Market report?

Ans: The main players in the Stem Cell Drugs Market are JCR Pharmaceuticals Co., Ltd, CORESTEM, Inc, Pharmicell Co., Ltd, Anterogen, Chiesi Pharmaceuticals, Takeda, New York Blood Center, MEDIPOST

What are the Application segmentation covered in the Stem Cell Drugs Market report?

Ans: The Applications covered in the Stem Cell Drugs Market report are Acute Graft-versus-Host Disease, Crohn’s Disease, Amyotrophic Lateral Sclerosis, Osteoarthritis, Others

What are the Type segmentation covered in the Stem Cell Drugs Market report?

Ans: The Types covered in the Stem Cell Drugs Market report are Cord Blood-Derived, Adipose-Derived, Bone Marrow-Derived, Others

Recommended Reports

Drug Development & Testing

Cell & Personalized Therapy

Pharmaceutical Market Services

1 Stem Cell Drugs Market Overview
1.1 Product Definition
1.2 Stem Cell Drugs by Type
1.2.1 Global Stem Cell Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Cord Blood-Derived
1.2.3 Adipose-Derived
1.2.4 Bone Marrow-Derived
1.2.5 Others
1.3 Stem Cell Drugs by Application
1.3.1 Global Stem Cell Drugs Market Value by Application (2024 VS 2031)
1.3.2 Acute Graft-versus-Host Disease
1.3.3 Crohn’s Disease
1.3.4 Amyotrophic Lateral Sclerosis
1.3.5 Osteoarthritis
1.3.6 Others
1.4 Global Stem Cell Drugs Market Size Estimates and Forecasts
1.4.1 Global Stem Cell Drugs Revenue 2020-2031
1.4.2 Global Stem Cell Drugs Sales 2020-2031
1.4.3 Global Stem Cell Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Stem Cell Drugs Market Competition by Manufacturers
2.1 Global Stem Cell Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Stem Cell Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Stem Cell Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Stem Cell Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Stem Cell Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Stem Cell Drugs, Product Type & Application
2.7 Global Key Manufacturers of Stem Cell Drugs, Date of Enter into This Industry
2.8 Global Stem Cell Drugs Market Competitive Situation and Trends
2.8.1 Global Stem Cell Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Stem Cell Drugs Players Market Share by Revenue
2.8.3 Global Stem Cell Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Stem Cell Drugs Market Scenario by Region
3.1 Global Stem Cell Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Stem Cell Drugs Sales by Region: 2020-2031
3.2.1 Global Stem Cell Drugs Sales by Region: 2020-2025
3.2.2 Global Stem Cell Drugs Sales by Region: 2026-2031
3.3 Global Stem Cell Drugs Revenue by Region: 2020-2031
3.3.1 Global Stem Cell Drugs Revenue by Region: 2020-2025
3.3.2 Global Stem Cell Drugs Revenue by Region: 2026-2031
3.4 North America Stem Cell Drugs Market Facts & Figures by Country
3.4.1 North America Stem Cell Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Stem Cell Drugs Sales by Country (2020-2031)
3.4.3 North America Stem Cell Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Stem Cell Drugs Market Facts & Figures by Country
3.5.1 Europe Stem Cell Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Stem Cell Drugs Sales by Country (2020-2031)
3.5.3 Europe Stem Cell Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Stem Cell Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Stem Cell Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Stem Cell Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Stem Cell Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Stem Cell Drugs Market Facts & Figures by Country
3.7.1 Latin America Stem Cell Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Stem Cell Drugs Sales by Country (2020-2031)
3.7.3 Latin America Stem Cell Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Stem Cell Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Stem Cell Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Stem Cell Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Stem Cell Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Stem Cell Drugs Sales by Type (2020-2031)
4.1.1 Global Stem Cell Drugs Sales by Type (2020-2025)
4.1.2 Global Stem Cell Drugs Sales by Type (2026-2031)
4.1.3 Global Stem Cell Drugs Sales Market Share by Type (2020-2031)
4.2 Global Stem Cell Drugs Revenue by Type (2020-2031)
4.2.1 Global Stem Cell Drugs Revenue by Type (2020-2025)
4.2.2 Global Stem Cell Drugs Revenue by Type (2026-2031)
4.2.3 Global Stem Cell Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Stem Cell Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Stem Cell Drugs Sales by Application (2020-2031)
5.1.1 Global Stem Cell Drugs Sales by Application (2020-2025)
5.1.2 Global Stem Cell Drugs Sales by Application (2026-2031)
5.1.3 Global Stem Cell Drugs Sales Market Share by Application (2020-2031)
5.2 Global Stem Cell Drugs Revenue by Application (2020-2031)
5.2.1 Global Stem Cell Drugs Revenue by Application (2020-2025)
5.2.2 Global Stem Cell Drugs Revenue by Application (2026-2031)
5.2.3 Global Stem Cell Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Stem Cell Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 JCR Pharmaceuticals Co., Ltd
6.1.1 JCR Pharmaceuticals Co., Ltd Company Information
6.1.2 JCR Pharmaceuticals Co., Ltd Description and Business Overview
6.1.3 JCR Pharmaceuticals Co., Ltd Stem Cell Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 JCR Pharmaceuticals Co., Ltd Stem Cell Drugs Product Portfolio
6.1.5 JCR Pharmaceuticals Co., Ltd Recent Developments/Updates
6.2 CORESTEM, Inc
6.2.1 CORESTEM, Inc Company Information
6.2.2 CORESTEM, Inc Description and Business Overview
6.2.3 CORESTEM, Inc Stem Cell Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 CORESTEM, Inc Stem Cell Drugs Product Portfolio
6.2.5 CORESTEM, Inc Recent Developments/Updates
6.3 Pharmicell Co., Ltd
6.3.1 Pharmicell Co., Ltd Company Information
6.3.2 Pharmicell Co., Ltd Description and Business Overview
6.3.3 Pharmicell Co., Ltd Stem Cell Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Pharmicell Co., Ltd Stem Cell Drugs Product Portfolio
6.3.5 Pharmicell Co., Ltd Recent Developments/Updates
6.4 Anterogen
6.4.1 Anterogen Company Information
6.4.2 Anterogen Description and Business Overview
6.4.3 Anterogen Stem Cell Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Anterogen Stem Cell Drugs Product Portfolio
6.4.5 Anterogen Recent Developments/Updates
6.5 Chiesi Pharmaceuticals
6.5.1 Chiesi Pharmaceuticals Company Information
6.5.2 Chiesi Pharmaceuticals Description and Business Overview
6.5.3 Chiesi Pharmaceuticals Stem Cell Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Chiesi Pharmaceuticals Stem Cell Drugs Product Portfolio
6.5.5 Chiesi Pharmaceuticals Recent Developments/Updates
6.6 Takeda
6.6.1 Takeda Company Information
6.6.2 Takeda Description and Business Overview
6.6.3 Takeda Stem Cell Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Takeda Stem Cell Drugs Product Portfolio
6.6.5 Takeda Recent Developments/Updates
6.7 New York Blood Center
6.7.1 New York Blood Center Company Information
6.7.2 New York Blood Center Description and Business Overview
6.7.3 New York Blood Center Stem Cell Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 New York Blood Center Stem Cell Drugs Product Portfolio
6.7.5 New York Blood Center Recent Developments/Updates
6.8 MEDIPOST
6.8.1 MEDIPOST Company Information
6.8.2 MEDIPOST Description and Business Overview
6.8.3 MEDIPOST Stem Cell Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 MEDIPOST Stem Cell Drugs Product Portfolio
6.8.5 MEDIPOST Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Stem Cell Drugs Industry Chain Analysis
7.2 Stem Cell Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Stem Cell Drugs Production Mode & Process Analysis
7.4 Stem Cell Drugs Sales and Marketing
7.4.1 Stem Cell Drugs Sales Channels
7.4.2 Stem Cell Drugs Distributors
7.5 Stem Cell Drugs Customer Analysis
8 Stem Cell Drugs Market Dynamics
8.1 Stem Cell Drugs Industry Trends
8.2 Stem Cell Drugs Market Drivers
8.3 Stem Cell Drugs Market Challenges
8.4 Stem Cell Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
JCR Pharmaceuticals Co Ltd
Corestem Inc
PHARMICELL
ANTEROGEN CO LTD
Chiesi Pharmaceuticals
Takeda
New York Blood Center
MediPost Co Ltd
List of Tables
 Table 1. Global Stem Cell Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Stem Cell Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Stem Cell Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Stem Cell Drugs Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Stem Cell Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Stem Cell Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Stem Cell Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Stem Cell Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Stem Cell Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Stem Cell Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Stem Cell Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Stem Cell Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Stem Cell Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stem Cell Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Stem Cell Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Stem Cell Drugs Sales by Region (2020-2025) & (K Units)
 Table 18. Global Stem Cell Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Stem Cell Drugs Sales by Region (2026-2031) & (K Units)
 Table 20. Global Stem Cell Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Stem Cell Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Stem Cell Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Stem Cell Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Stem Cell Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Stem Cell Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Stem Cell Drugs Sales by Country (2020-2025) & (K Units)
 Table 27. North America Stem Cell Drugs Sales by Country (2026-2031) & (K Units)
 Table 28. North America Stem Cell Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Stem Cell Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Stem Cell Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Stem Cell Drugs Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Stem Cell Drugs Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Stem Cell Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Stem Cell Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Stem Cell Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Stem Cell Drugs Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Stem Cell Drugs Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Stem Cell Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Stem Cell Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Stem Cell Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Stem Cell Drugs Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Stem Cell Drugs Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Stem Cell Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Stem Cell Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Stem Cell Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Stem Cell Drugs Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Stem Cell Drugs Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Stem Cell Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Stem Cell Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Stem Cell Drugs Sales (K Units) by Type (2020-2025)
 Table 51. Global Stem Cell Drugs Sales (K Units) by Type (2026-2031)
 Table 52. Global Stem Cell Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Stem Cell Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Stem Cell Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Stem Cell Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Stem Cell Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Stem Cell Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Stem Cell Drugs Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Stem Cell Drugs Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Stem Cell Drugs Sales (K Units) by Application (2020-2025)
 Table 61. Global Stem Cell Drugs Sales (K Units) by Application (2026-2031)
 Table 62. Global Stem Cell Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Stem Cell Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Stem Cell Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Stem Cell Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Stem Cell Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Stem Cell Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Stem Cell Drugs Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Stem Cell Drugs Price (US$/Unit) by Application (2026-2031)
 Table 70. JCR Pharmaceuticals Co., Ltd Company Information
 Table 71. JCR Pharmaceuticals Co., Ltd Description and Business Overview
 Table 72. JCR Pharmaceuticals Co., Ltd Stem Cell Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. JCR Pharmaceuticals Co., Ltd Stem Cell Drugs Product
 Table 74. JCR Pharmaceuticals Co., Ltd Recent Developments/Updates
 Table 75. CORESTEM, Inc Company Information
 Table 76. CORESTEM, Inc Description and Business Overview
 Table 77. CORESTEM, Inc Stem Cell Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. CORESTEM, Inc Stem Cell Drugs Product
 Table 79. CORESTEM, Inc Recent Developments/Updates
 Table 80. Pharmicell Co., Ltd Company Information
 Table 81. Pharmicell Co., Ltd Description and Business Overview
 Table 82. Pharmicell Co., Ltd Stem Cell Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Pharmicell Co., Ltd Stem Cell Drugs Product
 Table 84. Pharmicell Co., Ltd Recent Developments/Updates
 Table 85. Anterogen Company Information
 Table 86. Anterogen Description and Business Overview
 Table 87. Anterogen Stem Cell Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Anterogen Stem Cell Drugs Product
 Table 89. Anterogen Recent Developments/Updates
 Table 90. Chiesi Pharmaceuticals Company Information
 Table 91. Chiesi Pharmaceuticals Description and Business Overview
 Table 92. Chiesi Pharmaceuticals Stem Cell Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Chiesi Pharmaceuticals Stem Cell Drugs Product
 Table 94. Chiesi Pharmaceuticals Recent Developments/Updates
 Table 95. Takeda Company Information
 Table 96. Takeda Description and Business Overview
 Table 97. Takeda Stem Cell Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Takeda Stem Cell Drugs Product
 Table 99. Takeda Recent Developments/Updates
 Table 100. New York Blood Center Company Information
 Table 101. New York Blood Center Description and Business Overview
 Table 102. New York Blood Center Stem Cell Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. New York Blood Center Stem Cell Drugs Product
 Table 104. New York Blood Center Recent Developments/Updates
 Table 105. MEDIPOST Company Information
 Table 106. MEDIPOST Description and Business Overview
 Table 107. MEDIPOST Stem Cell Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. MEDIPOST Stem Cell Drugs Product
 Table 109. MEDIPOST Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Stem Cell Drugs Distributors List
 Table 113. Stem Cell Drugs Customers List
 Table 114. Stem Cell Drugs Market Trends
 Table 115. Stem Cell Drugs Market Drivers
 Table 116. Stem Cell Drugs Market Challenges
 Table 117. Stem Cell Drugs Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Stem Cell Drugs
 Figure 2. Global Stem Cell Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Stem Cell Drugs Market Share by Type: 2024 & 2031
 Figure 4. Cord Blood-Derived Product Picture
 Figure 5. Adipose-Derived Product Picture
 Figure 6. Bone Marrow-Derived Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Stem Cell Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Stem Cell Drugs Market Share by Application: 2024 & 2031
 Figure 10. Acute Graft-versus-Host Disease
 Figure 11. Crohn’s Disease
 Figure 12. Amyotrophic Lateral Sclerosis
 Figure 13. Osteoarthritis
 Figure 14. Others
 Figure 15. Global Stem Cell Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Stem Cell Drugs Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Stem Cell Drugs Sales (2020-2031) & (K Units)
 Figure 18. Global Stem Cell Drugs Average Price (US$/Unit) & (2020-2031)
 Figure 19. Stem Cell Drugs Report Years Considered
 Figure 20. Stem Cell Drugs Sales Share by Manufacturers in 2024
 Figure 21. Global Stem Cell Drugs Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Stem Cell Drugs Players: Market Share by Revenue in Stem Cell Drugs in 2024
 Figure 23. Stem Cell Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Stem Cell Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Stem Cell Drugs Sales Market Share by Country (2020-2031)
 Figure 26. North America Stem Cell Drugs Revenue Market Share by Country (2020-2031)
 Figure 27. United States Stem Cell Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Stem Cell Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Stem Cell Drugs Sales Market Share by Country (2020-2031)
 Figure 30. Europe Stem Cell Drugs Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Stem Cell Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Stem Cell Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Stem Cell Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Stem Cell Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Stem Cell Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Stem Cell Drugs Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Stem Cell Drugs Revenue Market Share by Region (2020-2031)
 Figure 38. China Stem Cell Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Stem Cell Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Stem Cell Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Stem Cell Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Stem Cell Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. China Taiwan Stem Cell Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Indonesia Stem Cell Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Thailand Stem Cell Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Malaysia Stem Cell Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Stem Cell Drugs Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Stem Cell Drugs Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Stem Cell Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Stem Cell Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Stem Cell Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Stem Cell Drugs Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Stem Cell Drugs Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Stem Cell Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Stem Cell Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. UAE Stem Cell Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Stem Cell Drugs by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Stem Cell Drugs by Type (2020-2031)
 Figure 59. Global Stem Cell Drugs Price (US$/Unit) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Stem Cell Drugs by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Stem Cell Drugs by Application (2020-2031)
 Figure 62. Global Stem Cell Drugs Price (US$/Unit) by Application (2020-2031)
 Figure 63. Stem Cell Drugs Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Cancer Stem Cell Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Plant Based Stem Cell Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Autologous Stem Cell and Non Stem Cell Based Therapies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Stem Cell Source Market Research Report 2024
Global Stem Cell Services Market Insights Forecast to 2030
Global Stem Cell Treatments Market Insights Forecast to 2030
Global Cell Regeneration Medicine Market Research Report 2024
Global Stem Cell Therapy Market Insights Forecast to 2030
Global Stem Cell Growth Factors Market Research Report 2025
Stem Cell Hair Transplant Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Stem Cell Lines Manufacturing Market Research Report 2024
Global Plant Stem Cell Market Research Report 2025
Global Stem Cell Equipment Market Research Report 2024
Hematopoietic Progenitor Cells Transplantation Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Stem Cell Cytokines Market Research Report 2024
Diabetes Stem Cell Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cell Therapy Regenerative Medicine Market Research Report 2025
Bone and Joint Regenerative Medicines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Autologous Stem Cell Based Therapies Market Research Report 2024
Global Stem Cell Wounds Therapy Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions